$MRNA | Bernstein SocGen Group đŋđ˛đļđđ˛đŋđŽđđ˛đ đ đŽđŋđ¸đ˛đ đŖđ˛đŋđŗđŧđŋđē on đ đŧđąđ˛đŋđģđŽ, maintains PT at $đ°đą
Analyst sees Intismeran as the clearest mRNA platform validation, with expansion now the key question.